Efficacy of Teeth Whitening Product Offerings in Adults

Efficacy of GLO Science Professional Teeth Whitening Product Offerings in Adults

This is a 30 day randomized, parallel comparative trial where participants with tooth shade of C2 or darker will be assigned to one of five groups. The participants will be evaluated for the difference in tooth shade, as determined by the digital VITA Easyshade V (provided by GLO) before the respective whitening regimen (baseline), immediately following the treatment period, and at 30 days (~4 weeks) from end of the treatment intervention.

Study Overview

• Status: Completed
• Conditions: Tooth Discoloration
• Intervention / Treatment: Other: Hydrogen peroxide teeth whitening gel; Device: GLO Science Professional Teeth Whitening Device; Device: GLO Brilliant Teeth Whitening Device; Device: GLO Lit Teeth Whitening Device

• Study Type: Interventional
• Enrollment (Actual): 75
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Arizona
    • Mesa, Arizona, United States, 85206
      • Arizona School of Dentistry & Oral Health

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Provide written informed consent to participate in the study.
• Be 18 to 65 years of age.
• Agree not to participate in any other oral/dental product studies during the trial.
• Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed.
• Agree to refrain from the use of any other teeth whitening products once assigned to a treatment group.
• Agree to refrain from the use of any oral care products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).
• Agree to return for all scheduled visits and follow study procedures.
• Be in good general health, as determined by the investigator/designee based on a review of the health history/update for participation in the study.
• Have at least 4 gradable maxillary anterior teeth ( canine to canine) with a Vita Shade average score of C2 or darker.
• Be willing to refrain from consuming stain-causing food and beverages (i.e., coffee, tea, red wine, berries, etc.) during the initial treatment duration (treatment period excluding the 4 week follow up).
• Be a current or recent non-smoker (no smoking for at least 3 months).

Exclusion Criteria:

• Are undergoing treatment for gingivitis, periodontitis, or caries.
• Presence of self-reported tooth sensitivity.
• Present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.
• Have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth ( canine to canine) or mandibular anterior teeth.
• Have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.
• Present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.
• Have meaningful malocclusion that would impact treatment or ease of viewing/scoring maxillary anterior teeth.
• Have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypocalcification.
• Have any known allergies to over-the-counter oral hygiene/whitening products.
• Have any known allergies to the trial product ingredients.
• Are pregnant and/or breastfeeding.
• Are current smokers.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: NONE

Number of Arms

5

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: GLO Science Professional Chairside Teeth Whitening	Other: Hydrogen peroxide teeth whitening gel; Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%; Device: GLO Science Professional Teeth Whitening Device; Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
EXPERIMENTAL: GLO Science Professional At-Home Teeth Whitening Device	Other: Hydrogen peroxide teeth whitening gel; Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%; Device: GLO Science Professional Teeth Whitening Device; Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
EXPERIMENTAL: GLO Brilliant At-Home Teeth Whitening Device	Other: Hydrogen peroxide teeth whitening gel; Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%; Device: GLO Brilliant Teeth Whitening Device; Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
EXPERIMENTAL: GLO Lit At-Home Teeth Whitening Device	Other: Hydrogen peroxide teeth whitening gel; Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%; Device: GLO Lit Teeth Whitening Device; Intra-oral mouthpiece connected to a battery in order to generate light and heat to effect the whitening treatment.
EXPERIMENTAL: GLO Lit Whitening GLO Vials	Other: Hydrogen peroxide teeth whitening gel; Hydrogen peroxide teeth whitening gel with concentrations ranging between 6% - 30%

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Tooth whitening efficacy: tooth shade value	Change in tooth shade value as indicated by the digital VITA Easyshade V	Immediately following treatment period (32 minutes, 5 days or 7 days), and after 30 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Tooth whitening safety: presence/absence of adverse events	Post-treatment dentinal hypersensitivity and the presence/absence of adverse events	Immediately following treatment period (32 minutes, 5 days or 7 days), and after 30 days

Collaborators and Investigators

• Sponsor: Glo Science, Inc.
• Collaborators: Arizona School of Dentistry & Oral Health, A. T. Still University
• Investigators: Principal Investigator: Ann Spolarich, RDH, PhD, Arizona School of Dentistry & Oral Health, A. T. Still University

Study record dates

Study Major Dates

• Study Start (ACTUAL): September 1, 2019
• Primary Completion (ACTUAL): November 30, 2019
• Study Completion (ACTUAL): December 30, 2019

Study Registration Dates

• First Submitted: October 10, 2019
• First Submitted That Met QC Criteria: October 10, 2019
• First Posted (ACTUAL): October 11, 2019

Study Record Updates

• Last Update Posted (ACTUAL): February 5, 2020
• Last Update Submitted That Met QC Criteria: February 4, 2020
• Last Verified: February 1, 2020

More Information

Terms related to this study

• Keywords: Tooth discoloration; Teeth whitening; Teeth bleaching
• Additional Relevant MeSH Terms: Stomatognathic Diseases; Tooth Diseases; Tooth Discoloration; Anti-Infective Agents, Local; Anti-Infective Agents; Hydrogen Peroxide
• Other Study ID Numbers: GLO-003

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes